Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Sep;8(1):6-17.

Pediatric brain tumor treatment: growth consequences and their management

Affiliations
Review

Pediatric brain tumor treatment: growth consequences and their management

Sogol Mostoufi-Moab et al. Pediatr Endocrinol Rev. 2010 Sep.

Abstract

Tumors of the central nervous system, the most common solid tumors of childhood, are a major source of cancer-related morbidity and mortality in children. Survival rates have improved significantly following treatment for childhood brain tumors, with this growing cohort of survivors at high risk of adverse medical and late effects. Endocrine morbidities are the most prominent disorder among the spectrum of longterm conditions, with growth hormone deficiency the most common endocrinopathy noted, either from tumor location or after cranial irradiation and treatment effects on the hypothalamic/pituitary unit. Deficiency of other anterior pituitary hormones can contribute to negative effects on growth, body image and composition, sexual function, skeletal health, and quality of life. Pediatric and adult endocrinologists often provide medical care to this increasing population. Therefore, a thorough understanding of the epidemiology and pathophysiology of growth failure as a consequence of childhood brain tumor, both during and after treatment, is necessary and the main focus of this review.

PubMed Disclaimer

Figures

Figure 1
Figure 1. GH system effects of craniospinal irradiation that decrease growth
Levels of all hormones are reduced. Normal growth hormone (GH) secretion is shown by the solid line; following irradiation by the dashed line. Decreased growth hormone releasing hormone (GHRH) secretion diminishes the growth hormone (GH) pulse amplitude and with time, leads to atrophy of the pituitary somatotrophs. Decreased somatostatin (ss) and insulin-like growth factor-1 (IGF-I) inhibition lead to enhanced tonic GH secretion by the remaining functional somatotrophs. Direct radiation injury to the thyroid and reduced thyroid stimulating hormone (TSH) secretion decrease thyroid hormone (T4) production, which further reduces GH secretion centrally and reduces growth plate responsiveness. Likewise, direct radiation injury to the spine decreases its growth response to GH.

References

    1. Packer RJ, MacDonald T, Vezina G. Central nervous system tumors. Pediatr Clin North Am. 2008;55(1):121–145. xi. - PubMed
    1. Bleyer WA. Epidemiologic impact of children with brain tumors. Childs Nerv Syst. 1999;15(11–12):758–763. - PubMed
    1. Packer RJ. Childhood brain tumors: accomplishments and ongoing challenges. J Child Neurol. 2008;23(10):1122–1127. - PMC - PubMed
    1. Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK. Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95(17):1276–1299. - PubMed
    1. Sklar CA. Overview of the effects of cancer therapies: the nature, scale and breadth of the problem. Acta Paediatr. 1999;88(suppl 433):1–4. - PubMed

Publication types

LinkOut - more resources